User profiles for Maria Saur Svane

Maria S Svane

Hvidovre Hospital
Verified email at regionh.dk
Cited by 1641

[HTML][HTML] Mechanisms in bariatric surgery: gut hormones, diabetes resolution, and weight loss

…, S Madsbad, KN Bojsen-Møller, MS Svane… - Surgery for Obesity and …, 2018 - Elsevier
Gastric bypass surgery leads to profound changes in the secretion of gut hormones with
effects on metabolism, appetite, and food intake. Here, we discuss their contributions to the …

[HTML][HTML] Gut hormones and their effect on bone metabolism. Potential drug therapies in future osteoporosis treatment

…, K Skov-Jeppesen, JA Windeløv, MS Svane… - Frontiers in …, 2019 - frontiersin.org
Bone homeostasis displays a circadian rhythm with increased resorption during the night
time as compared to day time, a difference that seems—at least partly—to be caused by food …

Bariatric surgery-effects on obesity and related co-morbidities

M Saur Svane, S Madsbad - Current Diabetes Reviews, 2014 - ingentaconnect.com
Laparoscopic adjustable gastric banding (LAGB), laparoscopic Roux-en-Y gastric bypass (RYGB)
and laparoscopic sleeve gastrectomy (SG) are the three most commonly performed …

In vivo and in vitro degradation of peptide YY3–36 to inactive peptide YY3–34 in humans

…, KN Bojsen-Møller, MS Svane… - American Journal …, 2016 - journals.physiology.org
Peptide YY (PYY) is a 36-amino-acid peptide released from enteroendocrine cells upon food
intake. The NH 2 terminally truncated metabolite, PYY 3–36 , exerts anorexic effects and …

[HTML][HTML] Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake

KN Bojsen-Møller, MS Svane, C Martinussen… - International Journal of …, 2023 - nature.com
Background/Objectives After Roux-en-Y gastric bypass (RYGB) a subset of patients never
obtain excess BMI loss (EBMIL) > 50% and are categorized as having primary weight loss (WL…

GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment

…, J Oeke, LJ Torz, S Veedfald, MS Svane… - Pharmacological …, 2022 - Elsevier
The intestinal hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like
peptide-2 (GLP-2) are key regulators of postprandial bone turnover in humans. We …

The Antiresorptive Effect of GIP, But Not GLP‐2, Is Preserved in Patients With Hypoparathyroidism—A Randomized Crossover Study

…, J Oeke, MS Hansen, A Jafari, MS Svane… - Journal of Bone and …, 2020 - academic.oup.com
Glucose‐dependent insulinotropic polypeptide (GIP) and glucagon‐like peptide‐2 (GLP‐2)
are gut hormones secreted postprandially. In healthy humans, both hormones decrease …

[HTML][HTML] Mechanisms of action of a carbohydrate-reduced, high-protein diet in reducing the risk of postprandial hypoglycemia after Roux-en-Y gastric bypass surgery

D Kandel, KN Bojsen-Møller, MS Svane… - The American journal of …, 2019 - Elsevier
Background Postprandial hypoglycemia is a risk after Roux-en-Y gastric bypass (RYGB).
Objectives We speculated that a carbohydrate-reduced, high-protein (CRHP) diet might reduce …

Updates in weight loss surgery and gastrointestinal peptides

MS Svane, KN Bojsen-Møller… - Current Opinion in …, 2015 - journals.lww.com
Changes in gut hormone secretion after RYGB and sleeve gastrectomy surgery induce the
beneficial effects on weight and glycemic control through the influence on appetite …

Augmented GLP-1 secretion as seen after gastric bypass may be obtained by delaying carbohydrate digestion

…, KN Bojsen-Møller, C Dirksen, MS Svane… - The Journal of …, 2019 - academic.oup.com
Context Exaggerated postprandial glucagon-like peptide-1 (GLP-1) secretion seems important
for weight loss and diabetes remission after Roux-en-Y gastric bypass (RYGB) and may …